# Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)

> **NCT03223909** · PHASE4 · COMPLETED · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 326 (actual)

## Conditions studied

- Dry Eye Syndrome

## Interventions

- **DRUG:** PRO-087
- **DRUG:** Systane Ultra
- **DRUG:** Systane Ultra Preservative Free

## Key facts

- **NCT ID:** NCT03223909
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-13
- **Primary completion:** 2018-10-16
- **Final completion:** 2018-12-16
- **Target enrollment:** 326 (ACTUAL)
- **Last updated:** 2019-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03223909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03223909, "Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03223909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*